Final-Program-ATS-2023-AP.vp

218

TUESDAY • MAY 23

9:44 A Case of Difficult-to-Treat Asthma: When Steroids Aren’t Enough S. Saxena, MD, Nashville, TN 9:56 Expert Discussant M. Hernandez, MD, Apex, NC 10:07 An Unusual Case of Hemoptysis Speaker: Kelsey Gavin, DO – Kansas City, MO 10:19 Expert Discussant D. Liptzin, MD, MS, Missoula, MT

9:13 A World of New Evidence: Fluid Volume, Choice, Timing, and Reversal in Sepsis Resuscitation T. Meyhoff, MD, Copenhagen, Denmark 9:26 Selecting and Adding Vasopressors in Septic Shock E. Munroe, MD, Ann Arbor, MI 9:39 Making it Personal: Individualizing Resuscitation Targets P. Bhatraju, MD, Seattle, WA 9:52 Unintended Consequences: Understanding Effects of New Resuscitation Strategies on Patient Care Processes C. Permpikul, MD, Bangkok, Thailand 10:05 Evidence to Practice: Teamwork Makes Resuscitation Work T. Hiller, BSN, RN, Denver, CO 10:18 Panel Discussion and Questions: What’s Next for Sepsis Resuscitation? This session and the International Conference are supported by an independent medical educational grant from AstraZeneca LP, Boehringer Ingelheim Pharmaceuticals, Inc., Insmed Incorporated, Vertex Pharmaceuticals, and United Therapeutics Corporation. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests). DISMANTLING STRUCTURAL RACISM FROM RISK AND DISEASE PREDICTION IN PULMONARY AND CRITICAL CARE MEDICINE Assemblies on Behavioral Science and Health Services Research; Critical Care 9:00 AM - 10:30 AM Marriott Marquis Washington Marquis Ballroom Salon 5 (Level M2) Target Audience Practicing clinicians and other health care providers, health disparities researchers, quality improvement specialists or policy makers Objectives At the conclusion of this session, the participant will be able to: • describe new findings about current biases in care delivery relevant to pulmonary/critical care medicine • identify the limitations of current approaches to clinical decision-making tools and treatment recommendations and evidence derived from machine learning approaches CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 1.5 C5

CLINICAL CRITICAL CARE TRACK CME Credits Available: 1.5

C4 FLUID AND VASOPRESSOR RESUSCITATION FOR EARLY SEPSIS: WHEN, WHICH, AND HOW MUCH? Assemblies on Critical Care; Behavioral Science and Health Services Research; Clinical Problems; Nursing 9:00 AM - 10:30 AM Walter E. Washington Convention Center West Salon G-I (Street Level) Target Audience Clinicians, researchers, trainees, and other team members, including nurses and pharmacists, who care for patients with early sepsis. Objectives At the conclusion of this session, the participant will be able to: • understand best practices for early sepsis resuscitation that are informed by high-quality evidence • identify areas of early sepsis management for which high-quality evidence is lacking • learn about trials currently in the field that will bring more data to inform practice for resuscitation and early sepsis management Hemodynamic resuscitation is a core element of sepsis management and a focus of guidelines and care bundles, yet the optimal approach to IV fluid administration and vasopressor use remains controversial. With growing concern about the harms of fluid overload, long-standing dogma is being challenged and practice is evolving towards fluid-sparing, early vasopressor strategies. This symposium will provide a comprehensive update on current controversies in hemodynamic resuscitation for sepsis, including discussion of brand new evidence addressing the timing and selection of fluids and vasopressors and strategies for real-world implementation. Chairing: E. Munroe, MD, Ann Arbor, MI I.D. Peltan, MD, MSc, Murray, UT I.S. Douglas, MD, FRCP, Denver, CO 9:00 Too Much of a Bad Thing? Pathophysiology of Harm from IV Fluids and Vasopressors in Sepsis I.S. Douglas, MD, FRCP, Denver, CO

ATS 2023 • Washington, DC